Novel co-delivery of oridonin and docetaxel nanoliposome for an enhanced antitumor effect on esophageal cancer.
Xi ChenHengyu MaoFeng PengJiang FanFu YangPublished in: The journal of gene medicine (2024)
The DOX/ORD NLPs prepared in this study can enhance the anti-tumor activity, and are expected to be a promising co-delivery platform for the treatment of esophageal cancer.